We are live on ! Find out more
PRDS

Pardes Biosciences, Inc. Common Stock
PRDS

Delisted

PRDS was delisted on the 30th of August, 2023.

Back to rankings

75 hedge funds and large institutions have $176M invested in Pardes Biosciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+75
Holders Change %
–
% of All Funds
1.32%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
75
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.3M
3
FCM
Farallon Capital Management
California
+$10.3M
4
JCM
JS Capital Management
New York
+$10.3M
5
PHS
PFM Health Sciences
California
+$10.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HP
51
Hound Partners
New York
$349K +$362K +35,000 New
PI
52
PEAK6 Investments
Illinois
$349K +$362K +35,000 New
PP
53
Paloma Partners
Connecticut
$334K +$346K +33,492 New
DAM
54
Deltec Asset Management
New York
$249K +$259K +25,000 New
MI
55
MMCAP International
Cayman Islands
$239K +$248K +23,946 New
BI
56
Bulldog Investors
New Jersey
$199K +$207K +20,000 New
EAM
57
Exos Asset Management
New York
$199K +$207K +20,000 New
SCC
58
Spring Creek Capital
Kansas
$199K +$207K +20,000 New
Tudor Investment Corp
59
Tudor Investment Corp
Connecticut
$199K +$207K +20,000 New
WRBC
60
W.R. Berkley Corp
Connecticut
$196K +$2.03M +196,650 New
CC
61
Centiva Capital
New York
$189K +$196K +19,000 New
E
62
Ergoteles
New York
$186K +$194K +18,718 New
Walleye Trading
63
Walleye Trading
New York
$122K +$127K +12,288 New
Toronto Dominion Bank
64
Toronto Dominion Bank
Ontario, Canada
$120K +$124K +12,002 New
WAM
65
Wolverine Asset Management
Illinois
$117K +$122K +11,782 New
LCG
66
Luxor Capital Group
New York
$112K +$117K +11,288 New
Calamos Advisors
67
Calamos Advisors
Illinois
$100K +$103K +10,000 New
DIG
68
DeepCurrents Investment Group
New York
$100K +$103K +10,000 New
DCM
69
Dupont Capital Management
Delaware
$100K +$103K +10,000 New
HM
70
Harvest Management
New York
$100K +$103K +10,000 New
TCM
71
Tenor Capital Management
New York
$100K +$103K +10,000 New
Royal Bank of Canada
72
Royal Bank of Canada
Ontario, Canada
$61K +$63.3K +6,124 New
VI
73
Vestcor Inc
New Brunswick, Canada
$4K +$4.14K +400 New
Morgan Stanley
74
Morgan Stanley
New York
$1K +$1.23K +119 New
Walleye Capital
75
Walleye Capital
New York
$184 +$191K +18,433 New
1 2
3

PRDS Hedge Fund Activity: Q1 2021 in Review

75 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Pardes Biosciences, Inc. Common Stock (PRDS) for Q1 2021, worth a combined $176M.

Buyers outnumbered sellers: 75 funds opened new PRDS positions and 0 closed out — a net gain of 75 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $17.7M.

  • 75 institutional investors held Pardes Biosciences, Inc. Common Stock (PRDS) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $176M of Pardes Biosciences, Inc. Common Stock stock for Q1 2021.
  • 75 funds opened new Pardes Biosciences, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +75 holders.
  • The largest Pardes Biosciences, Inc. Common Stock buyer in Q1 2021 was T. Rowe Price Associates, an estimated $17.7M added.

Based on aggregated 13F filings for Q1 2021.